Secretogranin III in human neuroendocrine tumours. A comparative immunohistochemical study with chromogranins A and B and secretogranin II

Regulatory Peptides

Volumn 165, Issue 1, 2010, Pages 30-35

  Portela Gomes, Guida Maria ^a   Grimelius, Lars ^b   Stridsberg, Mats ^b  

^a UNIVERSITY OF LISBON   (Portugal)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chromogranin A; Chromogranin B; Granins; Immunohistochemistry; Neuroendocrine tumours; Secretogranin II; Secretogranin III

Indexed keywords

CHROMOGRANIN A; CHROMOGRANIN B; SECRETOGRANIN II; SECRETOGRANIN III; SECRETONEURIN; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TISSUE DISTRIBUTION;

CHROMOGRANIN A; CHROMOGRANIN B; CHROMOGRANINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROENDOCRINE TUMORS; SECRETOGRANIN II;

EID: 78649810719     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.06.002     Document Type: Article

References (41)

1. Helle K.B. The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Biol Rev Camb Philos Soc 2004, 79:769-794.
2. Portela-Gomes G.M., Stridsberg M., Johansson H., Grimelius L. Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract. J Histochem Cytochem 1997, 45:815-822.
3. Portela-Gomes G.M., Stridsberg M. Selective processing of chromogranin A in the different islet cells in human pancreas. J Histochem Cytochem 2001, 49:483-490.
4. Portela-Gomes G.M., Stridsberg M. Region-specific antibodies to chromogranin B display various immunostaining patterns in human endocrine pancreas. J Histochem Cytochem 2002, 50:1023-1030.
5. Portela-Gomes G.M., Stridsberg M. Chromogranin A in the human gastrointestinal tract: an immunocytochemical study with region-specific antibodies. J Histochem Cytochem 2002, 50:1487-1492.
6. Portela-Gomes G.M., Grimelius L., Johansson H., Wilander E., Stridsberg M. Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies. Am J Surg Pathol 2001, 25:1261-1267.
7. Portela-Gomes G.M., Stridsberg M., Grimelius L., Falkmer U.G., Falkmer S. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas. An immunohistochemical study with region-specific antibodies. APMIS 2004, 112:663-673.
8. Portela-Gomes G.M., Grimelius L., Stridsberg M., Bresaola E., Viale G., Pelosi G. Expression of amino acid sequences of the chromogranin A molecule and synaptic vesicle protein 2 in neuroendocrine tumors of the lung. Virchows Arch 2005, 446:604-612.
9. Tartaglia A., Portela-Gomes G.M., Oberg K., Vezzadini P., Foschini M.P., Stridsberg M. Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies. Virchows Arch 2006, 448:399-406.
10. Weiler R., Feichtinger H., Schmid K.W., Fischer-Colbrie R., Grimelius L., Cedermark B., et al. Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids. Virchows Arch A Pathol Anat Histopathol 1987, 412:103-109.
11. Schmid K.W., Fischer-Colbrie R., Hagn C., Jasani B., Williams E.D., Winkler H. Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid. Am J Surg Pathol 1987, 11:551-556.
12. Lloyd R.V., Cano M., Rosa P., Hille A., Huttner W.B. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors. Am J Pathol 1988, 130:296-304.
13. Weiler R., Fischer-Colbrie R., Schmid K.W., Feichtinger H., Bussolati G., Grimelius L., et al. Immunological studies on the occurrence and properties of chromogranin A and B and secretogranin II in endocrine tumors. Am J Surg Pathol 1988, 12:877-884.
14. Wiedenmann B., Waldherr R., Buhr H., Hille A., Rosa P., Huttner W.B. Identification of gastroenteropancreatic neuroendocrine cells in normal and neoplastic human tissue with antibodies against synaptophysin, chromogranin A, secretogranin I (chromogranin B), and secretogranin II. Gastroenterology 1988, 95:1364-1374.
15. Bordi C., Yu J.Y., Baggi M.T., Davoli C., Pilato F.P., Baruzzi G., Gardini G., et al. Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer 1991, 67:663-672.
16. Schmid K.W., Brink M., Freytag G., Kirchmair R., Böcker W., Fischer-Colbrie R., et al. Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells. Virchows Arch 1994, 425:127-132.
17. Fahrenkamp A.G., Wibbeke C., Winde G., Ofner D., Böcker W., Fischer-Colbrie R., et al. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract. Virchows Arch 1995, 426:361-367.
18. Tötsch M., Padberg B.C., Schröder S., Ofner D., Böcker W., Fischer-Colbrie R., et al. Secretoneurin in bronchopulmonary carcinoids - immunohistochemical comparison with chromogranins A and B and secretogranin II. Histopathology 1995, 26:357-361.
19. Le Gall F., Vallet V.S., Thomas D., De Monti M., Duval J., Ramee M.P. Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins. Pathol Res Pract 1997, 193:179-185.
20. Prommegger R., Obrist P., Ensinger C., Schwelberger H.G., Wolf C., Fischer-Colbrie R., et al. Secretoneurin in carcinoids of the appendix-immunohistochemical comparison with chromogranins A, B and secretogranin II. Anticancer Res 1998, 18:3999-4002.
21. Kimura N., Pilichowska M., Okamoto H., Kimura I., Aunis D. Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors. Mod Pathol 2000, 13:140-146.
22. Stridsberg M., Grimelius L., Portela-Gomes G.M. Immunohistochemical staining of human islet cells with region-specific antibodies against secretogranins II and III. J Anat 2008, 212:229-234.
23. Hosaka M., Suda M., Sakai Y., Izumi T., Watanabe T., Takeuchi T. Secretogranin III binds to cholesterol in the secretory granule membrane as an adapter for chromogranin A. J Biol Chem 2004, 279:3627-3634.
24. Hosaka M., Watanabe T., Sakai Y., Uchiyama Y., Takeuchi T. Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells. Mol Biol Cell 2002, 13:3388-3399.
25. Soga J., Tazawa K. Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases. Cancer 1971, 28:990-998.
26. Prasad P., Yanagihara A.A., Small-Howard A.L., Turner H., Stokes A.J. Secretogranin III directs secretory vesicle biogenesis in mast cells in a manner dependent upon interaction with chromogranin A. J Immunol 2008, 181:5024-5034.
27. Holthuis J.C., Jansen E.J., Martens G.J. Secretogranin III is a sulfated protein undergoing proteolytic processing in the regulated secretory pathway. J Biol Chem 1996, 271:17755-17760.
28. Stridsberg M., Eriksson B., Janson E.T. Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours. Regul Pept 2008, 148:95-98.
29. Kim T., Tao-Cheng J.H., Eiden L., Loh P.Y. Chromogranin A: an 'on/off' switch controlling dense-core secretory granule biogenesis. Cell 2001, 106:499-509.
30. Kim T., Zhang C.F., Sun Z., Wu H., Loh Y.P. Chromogranin A deficiency in transgenic mice leads to aberrant chromaffin granule biogenesis. J Neurosci 2005, 25:6958-6961.
31. Taupenot L., Harper K.L., Mahapatra N.R., Parmer R.J., O'Connor D.T. Intracellular protein trafficking into catecholamine storage vesicles: novel chimeric photoproteins visualized by deconvolution fluorescence microscopy. Ann N Y Acad Sci 2002, 971:262-265.
32. Loh Y.P., Kim T., Rodriguez Y.M., Cawley N.X. Secretory granule biogenesis and neuropeptide sorting to the regulated secretory pathway in neuroendocrine cells. J Mol Neurosci 2004, 22:63-71.
33. Courel M.C., Rodemer C., Nguyen S.T., et al. Secretory granule biogenesis in sympathoadrenal cells: identification of a granulogenic determinant in the secretory prohormone chromogranin. A J Biol Chem 2006, 281:38038-38051.
34. Chanat E., Weiss U., Huttner W.B. The disulfide bond in chromogranin B, which is essential for its sorting to secretory granules, is not required for its aggregation in the trans-Golgi network. FEBS Lett 1994, 351:225-230.
35. Courel M., Vasquez M.S., Hook V.Y., Mahata S.K., Taupenot L. Sorting of the neuroendocrine secretory protein Secretogranin II into the regulated secretory pathway: role of N- and C-terminal alpha-helical domains. J Biol Chem 2008, 283:11807-11822.
36. Portela-Gomes GM, Gayen JR, Grimelius L, Stridsberg M, Mahata SK. The importance of chromogranin A in the development and function of endocrine pancreas. Regul Pept 2008; 151:19-25. Erratum in: Regul Pept 2009; 153:93.
37. Federspiel B.H., Burke A.P., Sobin L.H., Shekitka K.M. Rectal and colonic carcinoids. A clinicopathological study of 84 cases. Cancer 1990, 65:135-140.
38. Schmid K.W., Hittmair A., Ladurner D., Sandbichler P., Gasser R., Tötsch M. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study. Virchows Arch A Pathol Anat Histopathol 1991, 418:295-299.
39. Schmid K.W., Morgan J.M., Baumert M., Fischer-Colbrie R., Böcker W., Jasani B. Calcitonin and calcitonin gene-related peptide mRNA detection in a population of hyperplastic parathyroid cells also expressing chromogranin B. Lab Invest 1995, 73:90-95.
40. Khan A., Tischler A.S., Patwardhan N.A. DeLellis RA. Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands: an immunohistochemical study. Endocr Pathol 2003, 14:249-255.
41. Lloyd R.V., Jin L., Fields K. Detection of chromogranins A and B in endocrine tissues with radioactive and biotinylated oligonucleotide probes. Am J Surg Pathol 1990, 14:35-43.